L-759,656

From WikiMD's WELLNESSPEDIA

L-759,656_Structure.svg

L-759,656 is a synthetic cannabinoid receptor agonist that is used in scientific research. It is a potent and selective agonist for the CB2 receptor, with a much lower affinity for the CB1 receptor. This selectivity makes it a valuable tool for studying the role of the CB2 receptor in various physiological processes.

Chemical Properties[edit]

L-759,656 has the chemical formula C23H21NO2 and a molecular weight of 343.42 g/mol. It is structurally related to other cannabinoids but has been modified to enhance its selectivity for the CB2 receptor.

Pharmacology[edit]

L-759,656 binds to the CB2 receptor with high affinity, exhibiting an EC50 value in the low nanomolar range. Its selectivity for the CB2 receptor over the CB1 receptor is significant, making it useful for distinguishing the effects mediated by these two receptor subtypes. The CB2 receptor is primarily found in the immune system, and its activation by L-759,656 can modulate immune responses and inflammation.

Research Applications[edit]

L-759,656 is used in various research settings to explore the therapeutic potential of CB2 receptor activation. Studies have investigated its effects on pain management, inflammation, and neuroprotection. Due to its selectivity, L-759,656 helps researchers understand the specific roles of CB2 receptors without the psychoactive effects typically associated with CB1 receptor activation.

Potential Therapeutic Uses[edit]

While L-759,656 itself is not used clinically, research involving this compound contributes to the development of new drugs targeting the CB2 receptor. Potential therapeutic areas include autoimmune diseases, chronic pain, and neurodegenerative disorders.

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.